Go Pro

Cloopen Group (RAAS) Financials

Cloopen Group logo
$2.03 +0.01 (+0.50%)
As of 07/10/2026
Annual Income Statements for Cloopen Group

Annual Income Statements for Cloopen Group

This table shows Cloopen Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-36 -35 -243 -907 -141 -58 -20 -34
Consolidated Net Income / (Loss)
-23 -34 -65 -142 -141 -58 -20 -34
Net Income / (Loss) Continuing Operations
-23 -34 -65 -142 -143 -58 -20 -34
Total Pre-Tax Income
-22 -33 -65 -140 -142 -58 -20 -34
Total Operating Income
-25 -33 -57 -143 -141 -61 -27 -35
Total Gross Profit
27 31 38 43 33 29 29 21
Total Revenue
73 85 111 118 86 80 79 77
Operating Revenue
73 85 111 118 86 80 79 77
Total Cost of Revenue
46 54 74 75 53 52 50 56
Operating Cost of Revenue
46 54 74 75 53 52 50 56
Total Operating Expenses
53 64 95 186 174 90 56 56
Selling, General & Admin Expense
13 15 37 69 46 27 13 16
Marketing Expense
21 25 31 47 38 32 26 20
Research & Development Expense
18 24 27 47 47 31 24 20
Other Operating Expenses / (Income)
- - 0.00 0.00 22 0.00 -6.79 0.00
Total Other Income / (Expense), net
3.14 -0.31 -8.23 2.86 -1.99 3.32 6.95 0.86
Interest & Investment Income
-0.64 0.16 0.15 0.65 -0.13 2.52 7.40 1.19
Other Income / (Expense), net
4.02 -0.17 -7.84 2.27 -1.80 0.80 -0.45 -0.32
Income Tax Expense
0.39 0.08 0.17 1.74 -0.05 -0.08 -0.04 -0.12
Net Income / (Loss) Attributable to Noncontrolling Interest
2.36 -2.34 -0.00 -0.09 -0.15 -0.37 -0.56 0.08
Basic Earnings per Share
($2.88) ($2.68) ($2.85) ($3.08) ($0.44) ($0.18) ($0.06) ($0.11)
Weighted Average Basic Shares Outstanding
91.08M 89.57M 85.10M 294.79M 321.89M 321.95M 322.95M 323.15M
Diluted Earnings per Share
($2.88) ($2.68) ($2.85) ($3.08) ($0.44) ($0.18) ($0.06) ($0.11)
Weighted Average Diluted Shares Outstanding
91.08M 89.57M 85.10M 294.79M 321.89M 321.95M 322.95M 323.15M
Weighted Average Basic & Diluted Shares Outstanding
91.08M 89.57M 85.10M 333.96M 333.96M 333.96M 333.70M 342.20M

Quarterly Income Statements for Cloopen Group

No quarterly income statements for Cloopen Group are available.


Annual Cash Flow Statements for Cloopen Group

This table details how cash moves in and out of Cloopen Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
2.13 10 21 131 -17 -20 37 -43
Net Cash From Operating Activities
-23 -23 -33 -37 -82 -73 -25 -33
Net Cash From Continuing Operating Activities
-23 -24 -33 -37 -81 -73 -25 -33
Net Income / (Loss) Continuing Operations
-23 -34 -65 -142 -141 -58 -20 -34
Consolidated Net Income / (Loss)
-23 -34 -65 -142 -141 -58 -20 -34
Depreciation Expense
1.12 1.26 1.33 1.65 2.01 1.24 1.05 0.72
Amortization Expense
- - 0.00 0.00 1.28 0.64 1.16 0.29
Non-Cash Adjustments To Reconcile Net Income
-1.40 10 41 70 49 9.75 -10 -2.28
Changes in Operating Assets and Liabilities, net
-0.46 -1.88 -10 33 8.30 -26 3.28 2.38
Net Cash From Investing Activities
0.30 -12 -15 -285 51 49 63 -11
Net Cash From Continuing Investing Activities
0.30 -12 -15 -285 51 49 63 -11
Purchase of Property, Plant & Equipment
-1.12 -0.73 -0.52 -1.16 -0.84 -0.11 -0.40 -0.11
Acquisitions
-0.19 -0.91 -0.41 -36 -17 -1.39 -0.04 -0.01
Purchase of Investments
-7.86 -5.70 -0.68 -23 -51 -4.67 -30 -64
Sale of Property, Plant & Equipment
0.00 0.07 0.01 0.00 0.00 0.00 0.00 0.00
Sale and/or Maturity of Investments
8.96 5.01 1.03 0.60 19 3.47 49 51
Other Investing Activities, net
0.00 -10 -14 -225 101 52 45 1.21
Net Cash From Financing Activities
24 47 70 384 -7.65 0.00 0.00 0.00
Net Cash From Continuing Financing Activities
24 47 70 458 -7.65 0.00 0.00 0.00
Effect of Exchange Rate Changes
1.14 -0.32 -1.65 -5.69 20 2.83 -1.63 1.85
Cash Income Taxes Paid
0.06 0.01 0.02 0.05 0.05 0.01 0.00 0.00

Quarterly Cash Flow Statements for Cloopen Group

No quarterly cash flow statements for Cloopen Group are available.


Annual Balance Sheets for Cloopen Group

This table presents Cloopen Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
83 133 475 335 251 216 197
Total Current Assets
74 123 425 311 230 197 177
Cash & Equivalents
24 46 103 76 53 88 46
Restricted Cash
0.13 0.29 0.11 0.08 0.63 1.42 4.02
Short-Term Investments
0.36 0.00 20 60 60 40 51
Accounts Receivable
28 86 25 19 21 17 21
Prepaid Expenses
9.73 15 21 16 15 16 16
Other Current Assets
12 27 256 140 80 34 38
Plant, Property, & Equipment, net
1.31 1.19 2.21 2.09 1.46 1.12 0.87
Total Noncurrent Assets
-197 -471 47 22 20 18 19
Long-Term Investments
5.06 7.27 20 8.49 7.61 7.41 7.62
Goodwill
0.00 0.00 19 7.89 7.67 7.46 7.78
Intangible Assets
1.65 1.54 7.59 2.46 2.01 1.59 1.33
Other Noncurrent Operating Assets
-204 -480 0.49 3.03 2.47 1.98 2.44
Total Liabilities & Shareholders' Equity
83 133 475 335 251 216 197
Total Liabilities
64 105 113 109 83 70 78
Total Current Liabilities
48 103 110 108 83 70 77
Accounts Payable
18 18 23 18 12 13 19
Accrued Expenses
9.28 13 26 35 18 14 15
Current Deferred Revenue
- - 45 - 51 42 43
Other Current Liabilities
17 68 0.25 54 1.48 0.82 1.21
Total Noncurrent Liabilities
220 431 3.17 1.25 0.43 0.71 0.55
Noncurrent Deferred & Payable Income Tax Liabilities
0.04 0.03 1.39 0.19 0.12 0.06 0.01
Other Noncurrent Operating Liabilities
205 431 0.52 1.07 0.31 0.65 0.54
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-186 -400 362 226 168 146 119
Total Preferred & Common Equity
-182 -401 362 227 169 147 120
Total Common Equity
-182 -401 362 227 169 147 120
Common Stock
0.01 0.01 1,737 1,622 1,579 1,538 1,607
Retained Earnings
-168 -412 -1,326 -1,366 -1,385 -1,366 -1,461
Treasury Stock
0.00 0.00 -13 -18 -17 -17 -17
Accumulated Other Comprehensive Income / (Loss)
-11 12 -36 -11 -8.07 -7.72 -9.10
Noncontrolling Interest
-3.77 0.39 -0.17 -0.47 -0.83 -1.37 -1.35

Quarterly Balance Sheets for Cloopen Group

No quarterly balance sheets for Cloopen Group are available.


Annual Metrics And Ratios for Cloopen Group

This table displays calculated financial ratios and metrics derived from Cloopen Group's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 328,740,348.00 333,957,986.00 333,957,986.00 333,957,986.00 333,703,515.00 342,204,171.00
DEI Adjusted Shares Outstanding
0.00 0.00 328,740,348.00 333,957,986.00 333,957,986.00 333,957,986.00 333,703,515.00 342,204,171.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -0.74 -2.72 -0.42 -0.17 -0.06 -0.10
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 16.60% 30.74% 6.15% -27.13% -6.56% -2.30% -2.51%
EBITDA Growth
0.00% -58.30% -98.27% -119.02% -0.44% 57.91% 56.89% -35.85%
EBIT Growth
0.00% -55.93% -94.73% -117.09% -1.61% 57.57% 54.59% -28.64%
NOPAT Growth
0.00% -30.55% -72.04% -150.93% 1.26% 56.47% 55.92% -29.61%
Net Income Growth
0.00% -48.13% -95.12% -117.00% 0.31% 58.95% 65.37% -69.76%
EPS Growth
0.00% 6.94% -6.46% -7.91% 85.73% 59.28% 66.29% -75.46%
Operating Cash Flow Growth
0.00% 0.77% -43.55% -12.18% -120.15% 11.60% 66.04% -33.79%
Free Cash Flow Firm Growth
0.00% 0.00% 16.25% -376.77% 104.41% -114.12% 350.09% -230.52%
Invested Capital Growth
0.00% 0.00% -119.48% 126.74% -64.81% -42.84% -80.10% 1.28%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - -
Gross Margin
37.59% 36.23% 33.91% 36.13% 38.12% 35.84% 36.76% 27.39%
EBITDA Margin
-27.73% -37.64% -57.09% -117.79% -162.36% -73.12% -32.26% -44.96%
Operating Margin
-34.77% -38.93% -51.23% -121.11% -164.10% -76.45% -34.49% -45.86%
EBIT Margin
-29.26% -39.13% -58.28% -119.19% -166.19% -75.45% -35.07% -46.28%
Profit (Net Income) Margin
-31.00% -39.38% -58.78% -120.16% -164.39% -72.22% -25.60% -44.58%
Tax Burden Percent
101.75% 100.24% 100.27% 101.24% 99.97% 99.86% 99.79% 99.66%
Interest Burden Percent
104.13% 100.42% 100.59% 99.58% 98.96% 95.84% 73.15% 96.65%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% -62.17% -66.16% -66.88% -259.49%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% -30.57% -54.78% -65.99% -251.72%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 14.03% 36.71% 54.07% 233.70%
Return on Equity (ROE)
0.00% 18.03% 22.31% 734.28% -48.13% -29.45% -12.81% -25.79%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% -516.55% 33.72% -11.64% 66.74% -260.76%
Operating Return on Assets (OROA)
0.00% -40.31% -60.06% -46.29% -35.31% -20.69% -11.79% -17.17%
Return on Assets (ROA)
0.00% -40.57% -60.58% -46.67% -34.93% -19.80% -8.61% -16.54%
Return on Common Equity (ROCE)
0.00% 17.66% 22.18% 738.45% -48.19% -29.54% -12.90% -26.06%
Return on Equity Simple (ROE_SIMPLE)
0.00% 18.40% 16.32% -39.22% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-18 -23 -40 -100 -99 -43 -19 -25
NOPAT Margin
-24.34% -27.25% -35.86% -84.77% -114.87% -53.51% -24.15% -32.10%
Net Nonoperating Expense Percent (NNEP)
0.00% -9.61% -7.34% -13.80% -31.59% -11.38% -0.89% -7.78%
Return On Investment Capital (ROIC_SIMPLE)
- - - -26.45% -43.46% -25.57% -13.01% -20.67%
Cost of Revenue to Revenue
62.41% 63.77% 66.09% 63.87% 61.88% 64.16% 63.24% 72.61%
SG&A Expenses to Revenue
18.42% 17.22% 33.36% 58.04% 53.77% 33.47% 16.37% 20.73%
R&D to Revenue
25.12% 28.25% 24.08% 39.51% 55.00% 38.97% 30.86% 25.96%
Operating Expenses to Revenue
72.36% 75.16% 85.14% 157.23% 202.22% 112.29% 71.25% 73.25%
Earnings before Interest and Taxes (EBIT)
-21 -33 -65 -141 -143 -61 -28 -35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-20 -32 -64 -139 -140 -59 -25 -34
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.88 1.41 1.71 0.24 5.32
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.95 1.48 1.82 0.26 5.75
Price to Revenue (P/Rev)
4.38 3.76 2.88 2.71 3.72 3.60 0.45 8.35
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.82 2.13 3.55 0.00 55.48
Enterprise Value to Revenue (EV/Rev)
0.00 3.59 2.43 1.64 2.05 2.09 0.00 6.91
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.81 0.61 0.00 3.28 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 -0.10 -0.01 0.05 0.01 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 -0.08 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 1.16 1.18 15.68 -0.46 -0.67 -0.82 -0.93
Leverage Ratio
0.00 -0.44 -0.37 -15.73 1.38 1.49 1.49 1.56
Compound Leverage Factor
0.00 -0.45 -0.37 -15.67 1.36 1.43 1.09 1.51
Debt to Total Capital
0.00% -11.26% -0.77% 4.44% 0.57% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% -2.31% -0.77% 4.10% 0.57% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% -8.95% 0.00% 0.33% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 2.26% -0.10% -0.04% -0.21% -0.50% -0.94% -1.14%
Common Equity to Total Capital
0.00% 109.00% 100.87% 95.61% 99.64% 100.50% 100.94% 101.14%
Debt to EBITDA
0.00 -0.59 -0.05 -0.12 -0.01 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.33 0.79 0.91 1.03 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 -0.47 0.00 -0.01 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 -0.81 -0.08 -0.17 -0.01 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.45 1.27 1.26 1.45 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 -0.65 0.00 -0.01 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 0.23 -3.09 -2.14 -4.37 -5.39 -7.90 -5.06
Noncontrolling Interest Sharing Ratio
0.00% 2.03% 0.58% -0.57% -0.11% -0.33% -0.70% -1.03%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 1.53 1.19 3.87 2.89 2.79 2.82 2.29
Quick Ratio
0.00 1.07 1.28 1.35 1.44 1.62 2.07 1.53
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 378 439 -1,215 54 -7.57 19 -25
Operating Cash Flow to CapEx
-2,096.39% -3,548.11% -6,482.66% -3,234.77% -9,738.54% -65,176.94% -6,241.00% -30,517.58%
Free Cash Flow to Firm to Interest Expense
0.00 1,266.62 821.11 -21,160.92 864.14 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-95.31 -77.80 -62.27 -650.49 -1,325.40 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-99.85 -79.99 -63.23 -670.60 -1,339.01 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 1.03 1.03 0.39 0.21 0.27 0.34 0.37
Accounts Receivable Turnover
0.00 3.06 1.96 2.14 3.88 4.00 4.17 4.09
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 65.20 89.27 69.50 40.05 45.33 60.86 76.98
Accounts Payable Turnover
0.00 3.05 4.06 3.62 2.60 3.43 3.91 3.52
Days Sales Outstanding (DSO)
0.00 119.38 186.18 170.94 94.04 91.15 87.49 89.14
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 119.77 89.93 100.77 140.27 106.32 93.42 103.84
Cash Conversion Cycle (CCC)
0.00 -0.38 96.25 70.17 -46.22 -15.17 -5.93 -14.70
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 -401 -880 235 83 47 9.42 9.54
Invested Capital Turnover
0.00 -0.42 -0.17 -0.37 0.54 1.24 2.77 8.08
Increase / (Decrease) in Invested Capital
0.00 -401 -479 1,115 -152 -35 -38 0.12
Enterprise Value (EV)
0.00 306 270 193 176 168 -102 529
Market Capitalization
320 320 320 320 320 290 36 640
Book Value per Share
$0.00 ($2.03) ($4.71) $1.10 $0.69 $0.51 $0.44 $0.36
Tangible Book Value per Share
$0.00 ($2.05) ($4.73) $1.02 $0.66 $0.49 $0.41 $0.33
Total Capital
0.00 -167 -397 379 227 168 146 119
Total Debt
0.00 19 3.08 17 1.29 0.00 0.00 0.00
Total Long-Term Debt
0.00 15 0.00 1.26 0.00 0.00 0.00 0.00
Net Debt
0.00 -10 -50 -126 -143 -121 -136 -109
Capital Expenditures (CapEx)
1.12 0.65 0.51 1.15 0.84 0.11 0.40 0.11
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 5.25 -24 208 69 34 -2.02 -2.33
Debt-free Net Working Capital (DFNWC)
0.00 30 22 331 205 148 127 99
Net Working Capital (NWC)
0.00 26 19 315 203 148 127 99
Net Nonoperating Expense (NNE)
4.86 10 26 42 43 15 1.14 9.56
Net Nonoperating Obligations (NNO)
0.00 -215 -480 -126 -143 -121 -136 -109
Total Depreciation and Amortization (D&A)
1.12 1.26 1.33 1.65 3.29 1.87 2.21 1.01
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 6.17% -21.41% 176.03% 79.68% 42.45% -2.57% -3.04%
Debt-free Net Working Capital to Revenue
0.00% 34.67% 20.19% 280.24% 237.91% 183.43% 161.63% 129.86%
Net Working Capital to Revenue
0.00% 30.14% 17.43% 267.09% 236.41% 183.43% 161.63% 129.86%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($45.12) ($19.62) ($0.44) ($0.18) ($0.06) ($0.11)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 328.74M 294.79M 321.89M 321.95M 322.95M 323.15M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($45.12) ($19.62) ($0.44) ($0.18) ($0.06) ($0.11)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 328.74M 294.79M 321.89M 321.95M 322.95M 323.15M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($45.12) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 85.10M 333.96M 333.96M 333.96M 333.70M 342.20M
Normalized Net Operating Profit after Tax (NOPAT)
-18 -23 -40 -84 -85 -43 -19 -25
Normalized NOPAT Margin
-24.34% -27.25% -35.86% -70.90% -98.90% -53.51% -24.15% -32.10%
Pre Tax Income Margin
-30.47% -39.29% -58.62% -118.69% -164.45% -72.32% -25.65% -44.73%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
-87.07 -111.67 -121.26 -2,451.14 -2,305.03 0.00 0.00 0.00
NOPAT to Interest Expense
-72.43 -77.78 -74.61 -1,743.41 -1,593.23 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-91.61 -113.86 -122.22 -2,471.25 -2,318.64 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-76.98 -79.97 -75.58 -1,763.52 -1,606.84 0.00 0.00 0.00
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-1.15% -5.32% -1.48% -0.61% -4.02% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Cloopen Group

No quarterly metrics and ratios for Cloopen Group are available.



Financials Breakdown Chart

Cloopen Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cloopen Group's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

The last 5 years of Cloopen Group's net income performance:
  • 2021: -$141.93 million
  • 2022: -$141.49 million
  • 2023: -$58.08 million
  • 2024: -$20.12 million
  • 2025: -$34.15 million

Cloopen Group's total operating income in 2025 was -$35.13 million, based on the following breakdown:
  • Total Gross Profit: $20.98 million
  • Total Operating Expenses: $56.11 million

Over the last 7 years, Cloopen Group's total revenue changed from $72.99 million in 2018 to $76.61 million in 2025, a change of 4.9%.

Cloopen Group's total liabilities were at $77.84 million at the end of 2025, a 10.6% increase from 2024, and a 21.4% increase since 2019.

In the past 6 years, Cloopen Group's cash and equivalents has ranged from $23.76 million in 2019 to $102.97 million in 2021, and is currently $46.35 million as of their latest financial filing in 2025.

Over the last 7 years, Cloopen Group's book value per share changed from 0.00 in 2018 to 0.36 in 2025, a change of 36.1%.



Financial statements for NYSE:RAAS last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners